Syapse enables biomedical researchers, managers, and business development professionals to:
Easily organize and share research, product, and program information
Discover new licensing and partnership opportunities
Collaborate on the development of innovative products. Our web-based, BioSemantic Platform manages research, products, and programs to enable more efficient research and development with less risk.
Founded by Jonathan Hirsch in March 2008, and based on his industry experience and graduate research at Stanford, Syapse's applications are designed to power a new era of biomedical product development, from genomics-driven personalized medicine to monoclonal antibody therapeutics.
Our BioSemantic Platform, consisting of a structured biomedical information database, configurable semantic models, and a scientifically intelligent search engine, powers a suite of integrated applications. These applications enable pharmaceutical, biotechnology, diagnostic, and medical device companies to easily organize and share information, and collaborate, both internally and with partners, in developing and commercializing new products.
Syapse's first product, Opportunity Management System, enables biomedical companies to easily discover new licensing and partnering opportunities that meet their precise scientific and commercial requirements. OMS matches biomedical opportunity sellers with buyers on a multi-dimensional basis of scientific, therapeutic, and commercial compatibility. Many top research institutions, pharmaceutical and biotechnology companies are early adopters of OMS. – less – More from ZoomInfo »